China Sxt Pharmaceuticals Stock Performance
| SXTC Stock | USD 3.08 0.27 9.61% |
China SXT holds a performance score of 4 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.69, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, China SXT will likely underperform. Use China SXT semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on China SXT.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in China SXT Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, China SXT exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 11.59 | Five Day Return 11.19 | Year To Date Return (21.03) | Ten Year Return (100.00) | All Time Return (100.00) |
Last Split Factor 1:25 | Last Split Date 2023-10-05 |
1 | China SXT Pharmaceuticals, Inc. announced that it expects to receive 2.84 million in funding - Marketscreener.com | 01/27/2025 |
2 | China SXT Pharmaceuticals, Inc. Sees Large Growth in Short Interest | 02/13/2025 |
3 | China SXT Pharmaceuticals Has Regained Compliance with Nasdaqs Minimum Bid Price Deficiency | 03/17/2025 |
4 | China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange - TipRanks | 03/19/2025 |
| Begin Period Cash Flow | 17.4 M |
China |
China SXT Relative Risk vs. Return Landscape
If you would invest 360.00 in China SXT Pharmaceuticals on December 26, 2024 and sell it today you would lose (52.00) from holding China SXT Pharmaceuticals or give up 14.44% of portfolio value over 90 days. China SXT Pharmaceuticals is currently generating 1.068% in daily expected returns and assumes 20.6781% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than China, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
China SXT Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China SXT's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as China SXT Pharmaceuticals, and traders can use it to determine the average amount a China SXT's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0516
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SXTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 20.68 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.07 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average China SXT is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China SXT by adding it to a well-diversified portfolio.
China SXT Fundamentals Growth
China Stock prices reflect investors' perceptions of the future prospects and financial health of China SXT, and China SXT fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Stock performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.0497 | ||||
| Profit Margin | (1.61) % | ||||
| Operating Margin | 7.34 % | ||||
| Current Valuation | (7.86 M) | ||||
| Shares Outstanding | 507.8 K | ||||
| Price To Earning | 5.73 X | ||||
| Price To Book | 0.11 X | ||||
| Price To Sales | 0.81 X | ||||
| Revenue | 1.93 M | ||||
| Gross Profit | 553.97 K | ||||
| EBITDA | (2.35 M) | ||||
| Net Income | (3.1 M) | ||||
| Cash And Equivalents | 15.52 M | ||||
| Cash Per Share | 5.78 X | ||||
| Total Debt | 2.65 M | ||||
| Debt To Equity | 0.68 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 50.24 X | ||||
| Cash Flow From Operations | (1.93 M) | ||||
| Earnings Per Share | (28.58) X | ||||
| Market Capitalization | 1.56 M | ||||
| Total Asset | 23.13 M | ||||
| Retained Earnings | (24.71 M) | ||||
| Working Capital | 5.33 M | ||||
About China SXT Performance
By analyzing China SXT's fundamental ratios, stakeholders can gain valuable insights into China SXT's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China SXT has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China SXT has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 193.53 | 136.18 | |
| Return On Tangible Assets | (0.13) | (0.15) | |
| Return On Capital Employed | (0.20) | (0.19) | |
| Return On Assets | (0.13) | (0.15) | |
| Return On Equity | (0.26) | (0.24) |
Things to note about China SXT Pharmaceuticals performance evaluation
Checking the ongoing alerts about China SXT for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for China SXT Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China SXT is way too risky over 90 days horizon | |
| China SXT appears to be risky and price may revert if volatility continues | |
| China SXT has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.93 M. Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 553.97 K. | |
| China SXT Pharmaceuticals currently holds about 15.52 M in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| China SXT has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange - TipRanks |
- Analyzing China SXT's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China SXT's stock is overvalued or undervalued compared to its peers.
- Examining China SXT's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China SXT's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China SXT's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China SXT's stock. These opinions can provide insight into China SXT's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Stock analysis
When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |